Latest Publications

Share:

Medical Products Supply Chain Week in Review – September 2021 #1

Over the last two weeks, the President signed Executive Orders requiring all federal employees and contractors to be vaccinated. The White House COVID-19 Response Team announced a $3 billion investment in the vaccine supply...more

Medical Products Supply Chain Week in Review – August 2021 #5

Last week, the White House COVID-19 Response Team encouraged school systems to implement a layered approach to prevention as schools return to in-person learning. Moderna submitted a Biologics License Application (BLA) for...more

Medical Products Supply Chain Week in Review – August 2021 #4

Last week, Roche announced a shortage of its drug Actmera/RoActmera, which is used to treat COVID-19. The company, however, does have a mitigation strategy that it plans to implement to lessen the impact. The White House...more

Medical Products Supply Chain Week in Review – August 2021 #3

Last week, the FDA amended the Moderna and Pfizer-BioNTech emergency use authorizations (EUAs) to allow an additional dose of the mRNA COVID-19 vaccine for immunocompromised individuals. In addition, the Secretaries of...more

Medical Products Supply Chain Week in Review – August 2021 #2

Last week, the Administration’s COVID-19 Response Team reported that the case numbers continue to rise in low-vaccination states, with most infections as a result of the Delta variant. Vaccination rates, however, are starting...more

Medical Products Supply Chain Week in Review – August 2021 #1

Last week, the Centers for Disease Control and Prevention (CDC) revised its mask guidance for fully vaccinated individuals. Also, while the Administration and several health care institutions evaluate the possibility of...more

Medical Products Supply Chain Week in Review – July 2021 #4

Last week, FDA Acting Commissioner Janet Woodcock testified before Congress on the role of the agency in the COVID-19 response and the way forward. The Administration reaffirms its commitment to combat the national and global...more

Medical Products Supply Chain Week in Review – July 2021 #3

Last week, six U.S. agencies updated an advisory to urge businesses to conduct human rights due diligence for supply chain links to Xinjiang, China. In addition, the Pfizer/BioNTech COVID-19 vaccine received Priority Review...more

Medical Products Supply Chain Week in Review – July 2021 #2

Last week, President Biden signed a comprehensive pro-competition Executive Order with various requirements affecting medical product supply chains, such as the ability to import prescription drugs from Canada and banning...more

COVID-19 Medical Products Supply Chain Week in Review – July 2021 #1

Last week, the White House released a framework for U.S. leadership in the global COVID-19 response. In addition, the FDA is revoking the emergency use authorizations (EUAs) of all non-NIOSH-approved disposable respirators...more

COVID-19 Medical Products Supply Chain Week in Review – June 2021 #5

Last week, the FDA added new heart health risk information to mRNA vaccines’ fact sheets. In addition, the U.S. seized unauthorized COVID-19 drugs en route from Bangladesh and India to Mexico. ...more

The District of Columbia Continues to Fight the “True Lender” Rule in Court

A&B ABstract: Innovative partnerships between banks and nonbanks have expanded lending services to consumers and small businesses. These partnerships, known as marketplace lending arrangements, offer non-traditional loan...more

What Do the CFPB’s and FTC’s 2020 Debt Collection Activity Forecast for 2021?

Debt collectors can expect the Consumer Financial Protection Bureau and Federal Trade Commission to be active regulators in the Biden Administration, especially during – and in the wake of – the COVID-19 pandemic. Our...more

CFPB Brings Action Against Connecticut Mortgage Lender

Our Financial Services Litigation Team examines the latest effort by the Consumer Financial Protection Bureau to crack down on deceptive and unfair acts and practices – is it a harbinger of things to come under the Biden...more

CFPB, NCUA Sign MOU Regarding Cooperation

The Consumer Financial Protection Bureau (CFPB) and the National Credit Union Administration (NCUA) have signed a Memorandum of Understanding (MOU) to facilitate and improve coordination between the agencies. The CFPB and...more

Misrepresentation and Deception: Government Enforcement Agencies Ready to Litigate

A&B ABstract: The COVID-19 pandemic appears to be drafting the attention to consumer protection regulators to products that were active after the 2008 recession....more

CFPB Reflects on the Impact of COVID-19 and Provides a Window into Future Enforcement

Our financial services teams analyze how the Consumer Financial Protection Bureau is responding to consumer complaints about mortgage and credit card terms during the COVID-19 pandemic....more

Supreme Court Hears the CFPB Declare Itself Unconstitutional

Our Financial Services Litigation Team dives into the oral argument before the U.S. Supreme Court that could decide the fate of the Consumer Financial Protection Bureau....more

CFPB Issues Policy Statement on Dodd-Frank “Abusiveness” Standard, But Important Uncertainties Remain

A&B ABstract: The Consumer Financial Protection Bureau (“CFPB” or the “Bureau”) issued a Policy Statement to provide a framework for how it intends to apply the Dodd-Frank Act’s “abusiveness” standard going forward in its...more

California Governor Moves to Strengthen State Consumer Protection Enforcement in 2020

A&B ABstract: On January 10, 2020, California Governor Gavin Newsom released his budget summary for 2020 to 2021. ...more

Slaying the Monster? Reduced Risk of False Claims Act Prosecution for FHA Lenders

A&B Abstract: In an effort to incent large depository institutions to return to FHA lending, the U.S. Department of Housing and Urban Development (“HUD”) and the U.S. Department of Justice (“DOJ”) entered into a Memorandum...more

Supreme Court to Decide CFPB’s Constitutionality

A&B ABstract: On October 18, 2019, the Supreme Court granted certiorari in Seila Law v. CFPB to decide the constitutionality of the Consumer Financial Protection Bureau’s leadership structure....more

FATF Expands AML Recommendations to Cover Cryptocurrencies and Other Virtual Assets

Our White Collar, Government & Internal Investigations Group discusses how new guidance from the Financial Action Task Force affects virtual asset service providers (VASPs) and others that deal with virtual assets....more

The TCPA: After an Eventful 2018, Further Hope for 2019

Our TCPA Counseling & Litigation Team provides an overview of Telephone Consumer Protection Act news from 2018, highlighted by the D.C. Circuit’s ACA International decision, and a preview of a Supreme Court case coming in...more

49 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide